Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: Possible role of up-regulation of insulin-like growth factor-1 by hCG

International Journal of Cancer

Volumn 76, Issue 4, 1998, Pages 571-578

  Kuroda, Hideki ^a   Mandai, Masaki ^a   Konishi, Ikuo ^a   Yura, Yasuichiro ^a   Tsuruta, Yuko ^a   Hamid, Atia A ^a   Nanbu, Kanako ^a   Matsushita, Katsuko ^a   Mori, Takahide ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CISPLATIN; DNA FRAGMENT; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DIVISION; CHORIONIC GONADOTROPIN; CISPLATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OVARIAN NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031980408     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980518)76:4<571::AID-IJC21>3.0.CO;2-9     Document Type: Article

References (31)

1. ARENDS, M.J., MORRIS, R.G. and WYLLIE, A.H., Apoptosis: the role of the endonuclease. Amer. J. Pathol., 136, 593-608 (1990).
2. BALASCH, J. and BARRI, P.N., Follicular stimulation and ovarian cancer? Hum. Reprod., 8, 990-996 (1993).
3. BEDI, A., PASRICHA, P.J., AKHTAR, A.J., BARBER, J.P., BEDI, G.C., GIARDIELLO, F.M., ZEHNBAUER, B.A., HAMILTON, S.R. and JONES, R.J., Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55, 1811-1816 (1995).
4. BROWN, R., CLUGSTON, C. BURNS, P., EDLIN, A., VASEY, P., VOJTESCK, B. and KAYE, S, Increased accumulation of p53 protein in cisplatin-resistant ovarian cancer cell line. Int. J. Cancer, 55, 678-684 (1993).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
6. COHEN, J., FORMAN, R., HARLAP, S., JOHANNISSON, E., LUNENFELD, B., DE MOUZEN, J., PEPPERELL, R., TARLATZIS, B. and TEMPLETON, A., IFFS expert group report on the Whittemore study related to the risk of oxarian cancer associated with the use of infertility agents. Hum. Reprod., 8, 996-999 (1993).
7. DUNN, S.E., HARDMAN, R.A., KARI, F.W. and BARRETT, J.C., Insulin-like growth factor I (IGF-1) alters drug sensitivity of HBL 100 human breast cancer colls by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res., 57, 2687-2693 (1997).
8. ELLIS, R.E., YUAN, J.Y. and HORVITZ, H.R., Mechanisms and functions of cell death. Ann. Rev. Cell Biol., 154, 604-612 (1991).
9. EMONS, G., ORTMANN, O., BECKER, M., IRMER, G., SPRINGER, B., LAUN, R., HÖLZEL, F., SCHULZ, K.D. and SCHALLY, V., High affinity binding and direct antiproliterative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res., 53, 5439-5446 (1993).
10. EMONS, G., ORTMANN, O., TEICHERT, H.M., FASSL, H., LÖHRS, U., KULLANDER, S., KAUPILLA, A., AYALON, D., SCHALLY, A., and OBERHEUSER, F., Luteinizing hormone-releasing hormone agonist Triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. Decapeptyl Ovarian Cancer Study Group. Cancer, 78, 1452-1460 (1996).
11. GIBB, R.K., TAYLOR, D.D., WAN, T., O'CONNOR, D.M., DOERING, D.L. and GERCEL-TAYLOR, Ç.G., Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol. Oncol., 65, 13-22 (1997).
12. JUNG, Y.K., MIURA, M. and YUAN, J., Supression of interleukin-1β-converting enzyme-mediated cell death by insulin-like growth factor. J. biol. Chem., 271, 5112-5117 (1996).
13. KATAOKA, A., NISHIDA, T., MOTOMURA, S., HIGASHIJIMA, T., UEYAMA, T., SUGIYAMA,T. and YAKUSHIJI, M., The effects of sex steroid hormones, gonadotropins, and gonadotropin releasing hormone agonist on the proliferation of ovarian cancer cell line (KOC-2S). Acta Obstet. Gynecol. Jpn., 46, 1033-1040 (1994).
14. KERR, J.F., WYLLIE, A.H., and CURRIE, A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer. 26, 239-257 (1972).
15. KURODA, H., KONISHI, I., MANDAI, M., NANBU, K., MATSUSHITA, K., HAMID, A.A. and YURA, Y., Expression of LH/hCG receptors in human ovarian surface epithelial cells in vitro and the effect of hCG on the apoptosis [Abstract]. 56th Annual Meeting of Japanese Cancer Association. Jap. J. Cancer Res., 88 (Suppl.), 571 (1997a).
16. KURODA, H., KOMSHI, I., MANDAI, M., NANBU, K., RAO, C.V. and MORI, T., Ovarian cancer in infertile women during or after ovulation-induction therapy: expression of LH/hCG receptors and sex steroid receptors. Int. J. Gynecol. Cancer, 7, 451-457 (1997b).
17. LIN, J., LEI, Z.M. LOJUN, S., RAO, C.V. SATYASWAROOP, P.G. and DAY, T.G., Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J. clin. Endocrinol. Metab., 79, 1483-1491 (1994).
18. LIND, M.J., CANTWELL, B.M., MILLWARD, M.J., ROBINSON, A., PROCTOR, M., SIMMONS, D., CARMICHAEL, J. and HARRIS, A.L., A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer. Brit. J. Cancer. 65, 621-623 (1992).
19. MANDAI, M., KONISHI, I., KURODA, H., FUKUMOTO, M., KOMATSU, T., YAMAMOTO, S., NANBU, K., RAO, C.V. and MORI, T., Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Europ. J. Cancer. 33, 1501-1507 (1997).
20. NAKANO, R., KITAYAMA, S., YAMOTO, M., SHIMA, K. and OOSHIMA, A., Localization of gonadotropin binding sites in human ovarian neoplasms. Amer. J. Obstet. Gynecol. 161, 905-910 (1989).
21. OHTANI, K., SAKAMOTO, H. and SATOH, K., Stimulatory effects of follicular stimulating hormone on the proliferation of ovarian cancer cell line in vitro and in vivo. Acta Obstet. Gynecol. Jpn., 44, 717-724 (1992).
22. RAFF, M.C., Social controls on cell survival and cell death. Nature (Lond.), 356, 397-400 (1992).
23. RAO, B.R. and SLOTMAN, B.J., Endocrine factors in common epithelial ovarian cancer. Endocrinol.. Rev., 12, 14-26 (1991).
24. SIMON, W.E., ALBRECHT, M. HANSEL, M., DIETEL, M. and HOLZEL, F., Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J. Nat. Cancer Inst., 70, 839-845 (1483).
25. STOUFFER, F.L., GRODIN, M.S., DAVIS, J.R. and SURWIT, E.A., Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian carcinomas. J. clin. Endocrinol. Matab., 9, 441-446 (1984).
26. SUSSENBACH, J.S., The gene structure of the insulin-like growth factor family. Progr. Growth Factor Res., 1, 33-48 (1989).
27. TILLY, J.L. TILLY, K.I., KENTON, M.L. and JOHNSON, A.L., Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-x long messenger ribonucleic acid levels. Endocrinology, 136, 232-241 (1995).
28. ULLRICH, A. and 13 OTHERS, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5, 2503-2512 (1986).
29. WHITTEMORE, A.S., HARRIS, A.S. and ITNYRE, J., Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Amer. J. Epidemiol., 15, 1212-1220 (1992).
30. WIMALASENA, J., DOSTAL, R. and MEEHAN, D., Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol. Oncol., 46, 345-350 (1992).
31. ZHENG, W., MAGID, M.S., KRAMER, E. and CHEN, Y.T., Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Amer. J. Pathol., 148, 47-53 (1996).